1. Home
  2. IDYA vs XMTR Comparison

IDYA vs XMTR Comparison

Compare IDYA & XMTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

N/A

Current Price

$34.67

Market Cap

2.9B

Sector

Health Care

ML Signal

N/A

Logo Xometry Inc.

XMTR

Xometry Inc.

N/A

Current Price

$60.32

Market Cap

3.2B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
IDYA
XMTR
Founded
2015
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.2B
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
IDYA
XMTR
Price
$34.67
$60.32
Analyst Decision
Strong Buy
Buy
Analyst Count
14
9
Target Price
$49.33
$55.11
AVG Volume (30 Days)
964.1K
685.9K
Earning Date
02-12-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$214,834,000.00
$642,780,000.00
Revenue This Year
$2,688.43
$26.71
Revenue Next Year
N/A
$20.22
P/E Ratio
N/A
N/A
Revenue Growth
5377.66
22.40
52 Week Low
$13.45
$18.59
52 Week High
$39.28
$69.26

Technical Indicators

Market Signals
Indicator
IDYA
XMTR
Relative Strength Index (RSI) 47.60 45.30
Support Level $34.75 $62.00
Resistance Level $37.81 $66.50
Average True Range (ATR) 1.70 3.43
MACD -0.16 -0.61
Stochastic Oscillator 31.09 9.44

Price Performance

Historical Comparison
IDYA
XMTR

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About XMTR Xometry Inc.

Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.

Share on Social Networks: